• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[皮下注射肝素的局部耐受性。钙肝素与钠肝素的双盲比较(作者译)]

[Local tolerance of subcutaneous heparin. Double-blind comparison of calcium and sodium heparins (author's transl)].

作者信息

Blard J M, Rincon F, Nakache J P, Chastang C

出版信息

Sem Hop. 1979;55(1-2):45-9.

PMID:218296
Abstract

One hundred and twelve subcutaneous injections of concentrated heparin (25,000 IU/ml), half in sodium heparin and half in calciparine, both with an identical heparin cation, were given in doses varying from 0.2 ml to 0.5 ml by a single operator in a double-blind study to assess the comparative local tolerance of the two heparin salts. The occurrence of bruising at the point of injection, more frequent with sodium heparin than with Calciparine, proved to be the distinguishing factor. Overall after 48 hours, 31 hematomas were observed with the sodium salt versus 20 with calciparine. McNemar's test of comparing matched proportions confirms this result (p = 0.03) and, with the order of the two treatments taken into consideration, J.J. Gart's exact test gives p = 0.0101.

摘要

在一项双盲研究中,由一名操作人员以0.2毫升至0.5毫升不等的剂量,对112例患者进行皮下注射浓缩肝素(25,000国际单位/毫升),其中一半使用肝素钠,另一半使用卡奇普明,两种药物的肝素阳离子相同,以评估这两种肝素盐的相对局部耐受性。注射部位出现瘀伤的情况,肝素钠比卡奇普明更常见,这被证明是区分两者的因素。48小时后,总体上,使用钠盐观察到31例血肿,而使用卡奇普明观察到20例。比较匹配比例的McNemar检验证实了这一结果(p = 0.03),并且考虑到两种治疗的顺序,J.J. Gart精确检验得出p = 0.0101。

相似文献

1
[Local tolerance of subcutaneous heparin. Double-blind comparison of calcium and sodium heparins (author's transl)].[皮下注射肝素的局部耐受性。钙肝素与钠肝素的双盲比较(作者译)]
Sem Hop. 1979;55(1-2):45-9.
2
[Low dose heparin therapy. A study of the local effects of 5,000 international units of sodium heparin and calcium heparin].[低剂量肝素疗法。5000国际单位肝素钠和肝素钙局部作用的研究]
Ugeskr Laeger. 1979 Apr 30;141(18):1203-6.
3
A comparison between subcutaneous low-dose sodium and calcium heparin. Prophylaxis of postoperative deep vein thrombosis and side effects of treatment.皮下注射低剂量钠肝素与钙肝素的比较。术后深静脉血栓形成的预防及治疗副作用。
Acta Chir Scand. 1978;144(6):339-42.
4
Comparison of low-dose subcutaneous heparin calcium and heparin sodium on ecchymosis formation.低剂量皮下注射肝素钙与肝素钠对瘀斑形成的比较。
Clin Pharm. 1984 Mar-Apr;3(2):184-6.
5
Low dose subcutaneous heparin and wound hematoma formation in inguinal hernia operations--a double-blind randomized clinical trial.
Neth J Surg. 1981 Mar;33(1):19-22.
6
A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.在人类静脉血栓形成实验模型中对普通肝素和低分子量肝素(速碧林)的抗凝及抗血栓形成作用的比较研究。
Thromb Haemost. 1995 Nov;74(5):1286-92.
7
Concentrated or diluted heparin prophylaxis of postoperative deep venous thrombosis.浓缩或稀释肝素预防术后深静脉血栓形成。
Acta Chir Scand. 1978;144(5):283-8.
8
Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.低分子量肝素(KABI 2165)用于择期内脏手术的血栓预防。一项与普通肝素对比的随机双盲研究。
Thromb Haemost. 1986 Dec 15;56(3):243-6.
9
Optimal regimen of low-dose heparin prophylaxis in gastrointestinal surgery.胃肠道手术中低剂量肝素预防的最佳方案
Acta Chir Scand. 1979;145(2):87-93.
10
[Clinical trial of low doses of calcium heparin (Calciparine) in prevention of deep-vein thrombosis and pulmonary emboly in abdominal surgery (author's transl)].
Schweiz Rundsch Med Prax. 1974 May 28;63(21):646-50.

引用本文的文献

1
Clinical evaluation of pain during subcutaneous injections of low molecular weight heparins in healthy volunteers.健康志愿者皮下注射低分子量肝素时疼痛的临床评估
Br J Clin Pharmacol. 1994 Apr;37(4):395-7. doi: 10.1111/j.1365-2125.1994.tb04296.x.
2
Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.普通肝素和低分子量肝素的药物治疗学方面
Drugs. 1990 Oct;40(4):498-530. doi: 10.2165/00003495-199040040-00003.